BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17942891)

  • 1. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
    Hussain SF; Kong LY; Jordan J; Conrad C; Madden T; Fokt I; Priebe W; Heimberger AB
    Cancer Res; 2007 Oct; 67(20):9630-6. PubMed ID: 17942891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
    Kong LY; Wei J; Sharma AK; Barr J; Abou-Ghazal MK; Fokt I; Weinberg J; Rao G; Grimm E; Priebe W; Heimberger AB
    Cancer Immunol Immunother; 2009 Jul; 58(7):1023-32. PubMed ID: 19002459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for STAT3 inhibitors in glioblastoma.
    Jackson C; Ruzevick J; Amin AG; Lim M
    Neurosurg Clin N Am; 2012 Jul; 23(3):379-89. PubMed ID: 22748651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
    Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
    J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
    Kong LY; Abou-Ghazal MK; Wei J; Chakraborty A; Sun W; Qiao W; Fuller GN; Fokt I; Grimm EA; Schmittling RJ; Archer GE; Sampson JH; Priebe W; Heimberger AB
    Clin Cancer Res; 2008 Sep; 14(18):5759-68. PubMed ID: 18794085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
    Wei J; Wang F; Kong LY; Xu S; Doucette T; Ferguson SD; Yang Y; McEnery K; Jethwa K; Gjyshi O; Qiao W; Levine NB; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
    Cancer Res; 2013 Jul; 73(13):3913-26. PubMed ID: 23636127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.
    Akiyama Y; Nonomura C; Ashizawa T; Iizuka A; Kondou R; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Asai A; Ito M; Kiyohara Y; Yamaguchi K
    Immunol Lett; 2017 Oct; 190():20-25. PubMed ID: 28716484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
    Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
    J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3.
    Kowalczyk A; D'Souza CA; Zhang L
    Eur J Immunol; 2014 Apr; 44(4):1143-55. PubMed ID: 24338929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
    Natarajan C; Sriram S; Muthian G; Bright JJ
    Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.
    Finbloom DS; Winestock KD
    J Immunol; 1995 Aug; 155(3):1079-90. PubMed ID: 7543512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
    Chakravarti N; Myers JN; Aggarwal BB
    Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
    Wei J; Barr J; Kong LY; Wang Y; Wu A; Sharma AK; Gumin J; Henry V; Colman H; Priebe W; Sawaya R; Lang FF; Heimberger AB
    Mol Cancer Ther; 2010 Jan; 9(1):67-78. PubMed ID: 20053772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation and recruitment of ZAP-70 to the CD3-TCR complex are defective after CD2 stimulation.
    Hubert P; Lang V; Debré P; Bismuth G
    J Immunol; 1996 Nov; 157(10):4322-32. PubMed ID: 8906806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.
    Ott M; Kassab C; Marisetty A; Hashimoto Y; Wei J; Zamler D; Leu JS; Tomaszowski KH; Sabbagh A; Fang D; Gupta P; Priebe W; Zielinski RJ; Burks JK; Long JP; Kong LY; Fuller GN; DeGroot J; Sulman EP; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(18):4983-4994. PubMed ID: 32605912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
    Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L
    Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.